In vivo imaging of chronic active lesions in multiple sclerosis
No Thumbnail Available
Authors
Calvi, A
Haider, L
Prados, F
Tur, C
Chard, D
Barkhof, F
Issue Date
2022
Type
Scientific Paper
Language
Keywords
Research Subject Categories::MEDICINE::Dermatology and venerology,clinical genetics, internal medicine::Internal medicine::Neurology
Alternative Title
Abstract
New clinical activity in multiple sclerosis (MS) is often accompanied by acute inflammation which subsides. However, there is growing evidence that a substantial proportion of lesions remain active well beyond the acute phase. Chronic active lesions are most frequently found in progressive MS and are characterised by a border of inflammation associated with iron-enriched cells, leading to ongoing tissue injury. Identifying imaging markers for chronic active lesions in vivo are thus a major research goal. We reviewed the literature on imaging of chronic active lesion in MS, focussing on 'slowly expanding lesions' (SELs), detected by volumetric longitudinal magnetic resonance imaging (MRI) and 'rim-positive' lesions, identified by susceptibility iron-sensitive MRI. Both SELs and rim-positive lesions have been found to be prognostically relevant to future disability. Little is known about the co-occurrence of rims around SELs and their inter-relationship with other emerging techniques such as dynamic contrast enhancement (DCE) and positron emission tomography (PET).
Keywords: Multiple sclerosis; chronic active lesions; imaging; magnetic resonance imaging; positron emission tomography.
PubMed Disclaimer
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: F.P. received a non-clinical Guarantors of the Brain fellowship. C.T. has received an ECTRIMS Post-doctoral Research Fellowship in 2015. She has also received honoraria and support from travelling from Merck Serono, Sanofi, Roche, TEVA Pharmaceuticals, Novartis, Biogen, Bayer and Ismar Healthcare. D.C. is a consultant for Biogen and Hoffmann-La Roche. In the last 2 years, he has received research funding from the International Progressive MS Alliance, the MS Society and the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre. F.B. serves on the editorial boards of Brain, European Radiology, Journal of Neurology, Neurosurgery & Psychiatry, Neurology, Multiple Sclerosis and Neuroradiology and serves as a consultant for Bayer Schering Pharma, Sanofi-Aventis, Biogen-Idec, TEVA Pharmaceuticals, Genzyme, Merck Serono, Novartis, Roche, Synthon, Jansen Research and Lundbeck.
Figures
Figure 1.
Figure 1. Chronic active lesion pathology-imaging features:…
Similar articles
Measuring Pathology in Patients with Multiple Sclerosis Using Positron Emission Tomography.
Brier MR, Taha F.
Curr Neurol Neurosci Rep. 2023 Sep;23(9):479-488. doi: 10.1007/s11910-023-01285-z. Epub 2023 Jul 7.
PMID: 37418219 Review.
Central vein sign and iron rim in multiple sclerosis: ready for clinical use?
Preziosa P, Rocca MA, Filippi M.
Curr Opin Neurol. 2021 Aug 1;34(4):505-513. doi: 10.1097/WCO.0000000000000946.
PMID: 33928930 Review.
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H, Ohayon J, Wu T, Cortese ICM, Reich DS.
JAMA Neurol. 2019 Dec 1;76(12):1474-1483. doi: 10.1001/jamaneurol.2019.2399.
PMID: 31403674 Free PMC article.
Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.
Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Hurtado Rua SM, Park C, Gillen KM, Nguyen TD, Wang Y, Pitt D, Gauthier SA.
Brain. 2019 Jan 1;142(1):133-145. doi: 10.1093/brain/awy296.
PMID: 30561514 Free PMC article.
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Höftberger R, Berger T, Auff E, Leutmezer F, Trattnig S, Lassmann H, Bagnato F, Hametner S.
Acta Neuropathol. 2017 Jan;133(1):25-42. doi: 10.1007/s00401-016-1636-z. Epub 2016 Oct 27.
PMID: 27796537 Free PMC article.
See all similar articles
Cited by
The Time Trajectory of Choroid Plexus Enlargement in Multiple Sclerosis.
Andravizou A, Stavropoulou De Lorenzo S, Kesidou E, Michailidou I, Parissis D, Boziki MK, Stamati P, Bakirtzis C, Grigoriadis N.
Healthcare (Basel). 2024 Apr 1;12(7):768. doi: 10.3390/healthcare12070768.
PMID: 38610190 Free PMC article. Review.
Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature.
Beltrán-Velasco AI, Reiriz M, Uceda S, Echeverry-Alzate V.
Int J Mol Sci. 2024 Mar 5;25(5):3010. doi: 10.3390/ijms25053010.
PMID: 38474254 Free PMC article. Review.
Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years.
Reeves JA, Mohebbi M, Wicks T, Salman F, Bartnik A, Jakimovski D, Bergsland N, Schweser F, Weinstock-Guttman B, Dwyer MG, Zivadinov R.
Mult Scler. 2024 Apr;30(4-5):535-545. doi: 10.1177/13524585241229956. Epub 2024 Feb 17.
PMID: 38366920 Free PMC article.
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?
Hoffmann O, Gold R, Meuth SG, Linker RA, Skripuletz T, Wiendl H, Wattjes MP.
Ther Adv Neurol Disord. 2024 Feb 7;17:17562864241229325. doi: 10.1177/17562864241229325. eCollection 2024.
PMID: 38332854 Free PMC article. Review.
Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group.
QSM Consensus Organization Committee; Bilgic B, Costagli M, Chan KS, Duyn J, Langkammer C, Lee J, Li X, Liu C, Marques JP, Milovic C, Robinson SD, Schweser F, Shmueli K, Spincemaille P, Straub S, van Zijl P, Wang Y; ISMRM Electro-Magnetic Tissue Properties Study Group.
Magn Reson Med. 2024 May;91(5):1834-1862. doi: 10.1002/mrm.30006. Epub 2024 Jan 21.
PMID: 38247051
See all "Cited by" articles
References
Van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: Pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000; 26(1): 2–10. - PubMed
Bö L, Mörk S, Kong PA, et al.. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994; 51(2): 135–146. - PubMed
Brück W, Porada P, Poser S, et al.. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995; 38(5): 788–796. - PubMed
Kuhlmann T, Ludwin S, Prat A, et al.. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol 2017; 133(1): 13–24. - PubMed
Prineas JW, Parratt JDE. Oligodendrocytes and the early multiple sclerosis lesion. Ann Neurol 2012; 72(1): 18–31. - PubMed
Show all 63 references
Publication types
Review
Research Support, Non-U.S. Gov't
MeSH terms
Brain / pathology
Humans
Magnetic Resonance Imaging / methods
Multiple Sclerosis* / diagnostic imaging
Multiple Sclerosis* / pathology
Multiple Sclerosis, Chronic Progressive* / pathology
Positron-Emission Tomography
Related information
MedGen
PMC images
Description
Citation
Calvi A, Haider L, Prados F, Tur C, Chard D, Barkhof F. In vivo imaging of chronic active lesions in multiple sclerosis. Mult Scler. 2022 Apr;28(5):683-690. doi: 10.1177/1352458520958589. Epub 2020 Sep 23. PMID: 32965168; PMCID: PMC8978472.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
https://doi.org/10.1093/brain/awae013